Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Norgestomet is a synthetic steroidal progestin of the 19-norprogesterone group, developed for use in veterinary medicine. It is primarily used to control and synchronize estrus and ovulation in cattle. Norgestomet acts as an agonist of the progesterone receptor, exhibiting higher affinity for this receptor than natural progesterone. It has weak affinity for the glucocorticoid receptor at micromolar concentrations but does not significantly bind to estrogen receptors at therapeutic doses. The drug is typically administered via subcutaneous ear implant or injection, often in combination with estradiol valerate. Norgestomet was introduced for veterinary use in the mid‑1970s and is not approved for human medicine[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on norgestomet.